NGS is not only for genomics anymore:
How it powers high-throughput protein analysis​

This is proteomics, the Olink way—right on your sequencer.​

​NGS-based proteomics from Olink combines next-generation sequencing with our proprietary Proximity Extension Assay (PEA™) to enable high-throughput protein identification and quantification—without the high instrument cost and specialized expertise required for mass spectrometry. This patented technology uses dual-antibody recognition and DNA barcoding to convert protein binding events into unique DNA sequences, readable by your existing NGS platform. The result? Unmatched specificity, sensitivity, and scalability—making proteomics finally accessible to genomics researchers, and seamlessly expanding your multiomics capabilities without the need of specialized proteomics expertise.​​ With Olink® Explore HT and Olink® Reveal, high-throughput proteomics integrates directly into your NGS workflow—now you can start unlocking the protein layer using the tools you already trust.

From code to clarity: Proteomics completes the picture

Just one simple step with Olink’s NGS-based proteomics —
a leap forward for your genomics research.

While genomics gives us the blueprint, proteomics reveals real-time biology in action. Integrating proteomics with genomics bridges the gap between genotype and phenotype, providing a more complete understanding of human health and disease. With Olink’s NGS-based proteomics, you can seamlessly add protein-level insights to your genomic data—enabling more accurate disease modeling, faster biomarker discovery, and accelerated development of targeted therapies and diagnostics.

What happens when genomics meets proteomics at scale?
Hear from visionaries behind the UK Biobank Pharma Proteomics Project and see how this approach redefines the future of precision medicine.